| 3.9 |
15.6 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.5 |
1.5 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
1.4 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.3 |
2.4 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.3 |
3.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
6.6 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.2 |
0.7 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.2 |
1.4 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
1.4 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.1 |
1.8 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 |
0.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.8 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
1.2 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
1.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.4 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.6 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 |
6.5 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.1 |
4.0 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
2.3 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 |
0.5 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
1.1 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 |
0.2 |
GO:0051890 |
regulation of cardioblast differentiation(GO:0051890) |
| 0.0 |
0.3 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.0 |
1.4 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
1.0 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.9 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
1.8 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.3 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.0 |
0.6 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
